Stay updated on Dupilumab in Pediatric Peanut Allergy Clinical Trial
Sign up to get notified when there's something new on the Dupilumab in Pediatric Peanut Allergy Clinical Trial page.

Latest updates to the Dupilumab in Pediatric Peanut Allergy Clinical Trial page
- Check6 days agoNo Change Detected
- Check14 days agoChange DetectedAdded revision: v3.4.2; removed the funding-status notice and the prior revision: v3.4.1.SummaryDifference0.4%

- Check21 days agoChange DetectedA site-wide notice about government funding status and a version update (v3.4.1) were added. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

- Check28 days agoChange DetectedMinor UI/text updates: a 'Show glossary' option is displayed, the QC-related label is updated (Last Update Submitted that Met QC Criteria), and the revision is updated to v3.4.0 with capitalization tweaks for 'No FEAR Act Data'.SummaryDifference0.2%

- Check42 days agoChange DetectedA minor site revision update was made, adding Revision: v3.3.4 and removing Revision: v3.3.3. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check64 days agoChange DetectedA new dedicated Locations section has been added with regional site listings (California, Florida, Indiana, Michigan, New York, Ontario, Quebec), and the previous location groupings have been removed.SummaryDifference0.8%

- Check92 days agoChange DetectedPublications section wording updated to indicate that publications are automatically filled from PubMed and may not be about the study. The revision/version label was updated from v3.2.0 to v3.3.2.SummaryDifference0.1%

Stay in the know with updates to Dupilumab in Pediatric Peanut Allergy Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Dupilumab in Pediatric Peanut Allergy Clinical Trial page.